The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome

被引:20
|
作者
Dawood, Alaaeldin [1 ]
Alkafrawy, Nabil [1 ]
Saleh, Said [2 ]
Noreldin, Rasha [3 ]
Zewain, Shimaa [1 ]
机构
[1] Menoufia Univ, Internal Med, Shibin Al Kawm, Egypt
[2] Menoufia Univ, Obstet & Gynecol, Fac Med, Shibin Al Kawm, Egypt
[3] Menoufia Univ, Clin Pathol, Shibin Al Kawm, Egypt
关键词
Polycystic ovary; interleukin-18; cardiovascular disease risk; INSULIN-RESISTANCE; INTERLEUKIN-18; MARKERS; INFLAMMATION; PCOS;
D O I
10.1080/09513590.2017.1395835
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. The evidence in support of low-grade inflammation in PCOS as an etiology is emerging. Inflammation is likely to be associated with other prominent aspects of PCOS including insulin resistance (IR) and cardiovascular disease (CVD) risk. Interleukin-18 (IL-18) is considered as a strong marker of inflammation.Objectives: Evaluation of the relation between serum IL-18 and atherosclerotic CVD (ASCVD) risk in Egyptian lean females with PCO.Methods: This study included control group of healthy lean normally menstruating females, lean PCOS group (BMI<25kg/m(2)), and obese PCOS group (BMI>25kg/m(2)) presented with infertility and diagnosed according to Rotterdam criteria. Measurements of serum lipid profile, IR, and IL-18 were done.Results: Lipid accumulation product (LAP), IR and ASCVD risk were significantly higher in PCOS patients (lean and obese) compared to controls and in obese compared to lean. Serum IL-18 was significantly higher in the PCOV groups compared to the controls and correlated directly with LAP, IR and ASCVD risk.Conclusion: IL-18 is elevated in PCOS patients even in lean ones and is correlated with IR and ASCVD risk.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 50 条
  • [41] Cardiovascular health in women with polycystic ovary syndrome
    Sukalich, S
    Guzick, D
    SEMINARS IN REPRODUCTIVE MEDICINE, 2003, 21 (03) : 309 - 315
  • [42] Vascular risk in young women with polycystic ovary and polycystic ovary syndrome
    Battaglia, Cesare
    Mancini, Fulvia
    Cianciosi, Arianna
    Busacchi, Paolo
    Facchinetti, Fabio
    Marchesini, Giulio Reggiani
    Marzocchi, Rebecca
    de Aloysio, Domenico
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 385 - 395
  • [43] Cardiovascular risk and events in polycystic ovary syndrome
    Carmina, E.
    CLIMACTERIC, 2009, 12 : 22 - 25
  • [44] Cardiovascular risk factors in polycystic ovary syndrome
    Karaer, A.
    Cavkaytar, S.
    Mert, I.
    Buyukkagnici, U.
    Batioglu, S.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 30 (04) : 387 - 392
  • [45] Polycystic ovary syndrome and cardiovascular risk profile
    Bohlen, Sophia-Marie
    Kiesel, Ludwig
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2024, 22 (03): : 216 - 220
  • [46] Polycystic ovary syndrome and cardiovascular disease risk
    Legro R.S.
    Current Cardiovascular Risk Reports, 2009, 3 (1) : 65 - 70
  • [47] Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
    Pandurevic, Srdan
    Macut, Djuro
    Fanelli, Flaminia
    Pagotto, Uberto
    Gambineri, Alessandra
    BIOMOLECULES, 2021, 11 (09)
  • [48] Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome
    Kilic-Okman, T
    Guldiken, S
    Kucuk, M
    ENDOCRINE JOURNAL, 2004, 51 (05) : 505 - 508
  • [49] Study of the Relationship between Obesity and Infertility in Women with Polycystic Ovary Syndrome
    Hashemi, Amir Hossein
    Mozdarani, Hossein
    INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND RESEARCH, 2016, 7 (04): : 1237 - 1240
  • [50] Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
    Amiri, Mina
    Mousavi, Maryam
    Noroozzadeh, Mahsa
    Azizi, Fereidoun
    Tehrani, Fahimeh Ramezani
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2025, 23 (01)